CGS-21680

CGS-21680
Names
IUPAC name
3-[4-(2-{[6-Amino-9-(N-ethyl-β-D-ribofuranosyluronamide)-9H-purin-2-yl]amino}ethyl)phenyl]propanoic acid
Systematic IUPAC name
3-{4-[2-({6-Amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]-9H-purin-2-yl}amino)ethyl]phenyl}propanoic acid
Other names
CGS 21680
Identifiers
CAS Number
  • 120225-54-9 checkY
3D model (JSmol)
  • Interactive image
ChEBI
  • CHEBI:73283 ☒N
ChEMBL
  • ChEMBL331372 checkY
ChemSpider
  • 2343185 ☒N
IUPHAR/BPS
  • 375
  • 424
PubChem CID
  • 3086599
UNII
  • T5HB1E831H checkY
CompTox Dashboard (EPA)
  • DTXSID6043882 Edit this at Wikidata
InChI
  • InChI=1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1 ☒N
    Key: PAOANWZGLPPROA-RQXXJAGISA-N ☒N
  • InChI=1/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1
    Key: PAOANWZGLPPROA-RQXXJAGIBL
  • O=C(O)CCc1ccc(cc1)CCNc2nc(c3ncn(c3n2)[C@@H]4O[C@H](C(=O)NCC)[C@@H](O)[C@H]4O)N
Properties
Chemical formula
C23H29N7O6
Molar mass 499.52
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references
Chemical compound

CGS-21680 is a specific adenosine A2A subtype receptor agonist. It is usually presented as an organic hydrochloride salt with a molecular weight of 536.0 g/M. It is soluble up to 3.4 mg/mL in DMSO and 20 mg/mL in 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin.

The chemical is currently used by researchers interested in studying neuronal transmission with a high-affinity, subtype specific analogue for adenosine. This includes research in respiration where it is believed that A2A receptors are involved in rhythm generation in the pre-Bötzinger complex. The drug is not currently approved for use in a therapeutic capacity.

See also

References

  • Mayer CA, Haxhiu MA, Martin RJ, Wilson CG (2006). "Adenosine A2A receptors mediate GABAergic inhibition of respiration in immature rats". J Appl Physiol. 100 (1): 91–97. doi:10.1152/japplphysiol.00459.2005. PMID 16141383.
  • Xie S, Shafer G, Wilson CG, Martin HB (2006). "In vitro adenosine detection with a diamond-based sensor". Dia Rel Mater. 15 (2–3): 225–228. Bibcode:2006DRM....15..225X. doi:10.1016/j.diamond.2005.08.018.
  • v
  • t
  • e
Receptor
(ligands)
P0 (adenine)
P1
(adenosine)
  • Agonists: 2-(1-Hexynyl)-N-methyladenosine
  • 2-Cl-IB-MECA
  • 2'-MeCCPA
  • 4'-O-β-D-Glucosyl-9-O-(6''-deoxysaccharosyl)olivil
  • 5'-N-ethylcarboxamidoadenosine
  • Adenosine
  • ADP
  • AMP
  • Apadenoson
  • ATL-146e
  • ATP
  • BAY 60–6583
  • Binodenoson
  • Capadenoson
  • CCPA
  • CGS-21680
  • CP-532,903
  • Evodenoson
  • GR 79236
  • LUF-5835
  • LUF-5845
  • N6-Cyclopentyladenosine
  • Namodenoson
  • Neladenoson dalanate
  • Piclidenoson
  • Regadenoson
  • SDZ WAG 994
  • Selodenoson
  • Sonedenoson
  • Tecadenoson
  • UK-432,097
P2
(nucleotide)
P2X
(ATPTooltip Adenosine triphosphate)
P2Y
Transporter
(blockers)
CNTsTooltip Concentrative nucleoside transporters
ENTsTooltip Equilibrative nucleoside transporters
PMATTooltip Plasma membrane monoamine transporter
Enzyme
(inhibitors)
XOTooltip Xanthine oxidase
Others
Others
See also: Receptor/signaling modulators


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e